261 – 270 of 324
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Progress in haemophilic care: ethical issues.
(
- Contribution to journal › Article
-
Mark
Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.
(
- Contribution to journal › Article
-
Mark
Unresolved issues in prophylaxis
(
- Contribution to journal › Article
-
Mark
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen
(
- Contribution to journal › Article
-
Mark
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients
(
- Contribution to journal › Article
- 2001
-
Mark
Therapeutic choices for patients with hemophilia and high-titer inhibitors
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis
(
- Contribution to journal › Article
-
Mark
An approach to study the viral safety of plasma-derived products in previously treated, non-infected patients
(
- Contribution to journal › Article
-
Mark
Immune tolerance induction: recombinant vs. human-derived product
(
- Contribution to journal › Article
-
Mark
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
(
- Contribution to journal › Article